[DIABETIC RETINOPATHY AND ITS TREATMENT].
作者信息
DENEUMANN P S
出版信息
Arch Oftalmol B Aires. 1963 Jul;38:207-18.
PMID:14085250
Abstract
摘要
相似文献
1
[DIABETIC RETINOPATHY AND ITS TREATMENT].
Arch Oftalmol B Aires. 1963 Jul;38:207-18.
2
METABOLISM OF THE ALLOXAN DIABETIC RAT RETINA.
Arch Ophthalmol. 1964 Jan;71:73-6. doi: 10.1001/archopht.1964.00970010089014.
3
PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD.
J Clin Pathol. 1964 May;17(3):328-32. doi: 10.1136/jcp.17.3.328.
4
THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN.
Acta Cardiol. 1964;19:1-13.
5
[ORAL DIABETIC DRUGS].
Nord Med. 1964 Feb 20;71:243-5.
6
A REVIEW OF THE HISTORY OF THE TREATMENT OF DIABETES MELLITUS AND THE SEARCH FOR ORAL HYPOGLYCAEMIC AGENTS.
Guys Hosp Rep. 1964;113:45-54.
7
LONG-TERM CHLORPROPAMIDE THERAPY IN DIABETES: FOUR YEARS' EXPERIENCE.
J Am Geriatr Soc. 1964 Feb;12:195-201. doi: 10.1111/j.1532-5415.1964.tb00352.x.
8
ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
Med Times. 1964 Jul;92:645-54.
9
THE EYE AND THE ENDOCRINES.
Am J Ophthalmol. 1965 Jan;59:1-8. doi: 10.1016/0002-9394(65)95009-9.
10
Clinical experiences with chlorpropamide, with special reference to comparison with previous experience with carbutamide and tolbutamide.
Ann N Y Acad Sci. 1959 Mar 30;74(3):709-16. doi: 10.1111/j.1749-6632.1959.tb39600.x.
Zotero 插件